Amgen Inc 주식(AMGN)의 최신 뉴스
Amgen (NASDAQ:AMGN) Releases Earnings Results - MarketBeat
AMGN's Key Drugs Repatha, Evenity & Blincyto Drive Q1 Sales Growth - TradingView
Alteri Wealth LLC Buys Shares of 11,903 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Stock Outlook: Is Wall Street Bullish Or Bearish? - Barchart.com
Caisse DE Depot ET Placement DU Quebec Reduces Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Red Biotechnology Market to Witness Remarkable Growth with - openPR.com
Marshall Wace LLP Decreases Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
PDT Partners LLC Has $1.51 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bison Wealth LLC Reduces Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
The Manufacturers Life Insurance Company Sells 27,512 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Mercer Global Advisors Inc. ADV Buys Shares of 116,537 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen: Reducing My Price Target, Reiterate Buy After A Solid Q1 - Seeking Alpha
Meiji Yasuda Life Insurance Co Has $6.05 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
California State Teachers Retirement System Sells 23,730 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Trimmed by Public Employees Retirement Association of Colorado - MarketBeat
Northern Trust Corp Has $1.68 Billion Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,826 Shares in Amgen Inc. (NASDAQ:AMGN) Bought by Marshall & Sterling Wealth Advisors Inc. - MarketBeat
Beacon Pointe Advisors LLC Lowers Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Arrow Financial Corp Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
1,825 Shares in Amgen Inc. (NASDAQ:AMGN) Purchased by Westbourne Investments Inc. - MarketBeat
Voleon Capital Management LP Invests $1.52 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Nebula Research & Development LLC Purchases New Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. Reports Strong Growth Amid Challenges - TipRanks
Amgen (AMGN) Receives a Revised Price Target from UBS Analyst | - GuruFocus
Amgen (AMGN) Receives a Revised Price Target from UBS Analyst | AMGN Stock News - GuruFocus
Robots of Amgen - Amgen
Amgen's Better Than Expected Q1 Earnings Take Backseat As Eyes Are On MariTide Obesity Data - Benzinga
Amgen (AMGN): RBC Capital Maintains Rating, Lowers Price Target | AMGN Stock News - GuruFocus
Amgen (NasdaqGS:AMGN) Reports Strong Q1 Earnings With Revenue Increase To US$8 Billion - simplywall.st
Amgen’s Stelara biosimilar gets off to fast start - BioPharma Dive
Citigroup Adjusts Price Target on Amgen to $300 From $290 - marketscreener.com
Cantor Fitzgerald maintains neutral on Amgen stock, target at $305 - Investing.com
Cantor Fitzgerald maintains neutral on Amgen stock, target at $305 By Investing.com - Investing.com UK
Amgen Unusual Options Activity For May 02 - Nasdaq
Amgen (AMGN) Price Target Reduced by UBS Analyst | AMGN Stock News - GuruFocus
Amgen (AMGN) Surges After Beating Q1 Earnings Expectations - GuruFocus
Strong first-quarter product sales for Amgen - The Pharma Letter
Parvin Asset Management LLC Invests $1.46 Million in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Q1 2025 Earnings Call Transcript - Insider Monkey
Street View: Investor focus still on Amgen's weight-loss drug candidate - TradingView
UBS Adjusts Price Target on Amgen to $315 From $319, Maintains Neutral Rating - marketscreener.com
Navigoe LLC Makes New $390,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen's Q1 Earnings Beat Estimates, Key Drugs Drive Sales Growth - TradingView
Comerica Bank Decreases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Bridgewealth Advisory Group LLC Makes New $417,000 Investment in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Holdings Lowered by Becker Capital Management Inc. - MarketBeat
RBC Trims Price Target on Amgen to $320 From $324, Keeps Outperform Rating - marketscreener.com
Amgen’s Aflibercept Starts Strong As Regeneron Counts Cost Of Eylea Competition - insights.citeline.com
Amgen (AMGN) Surpasses Expectations with Strong Q1 Performance - GuruFocus
Amgen Inc (AMGN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Pricing Challenges - Yahoo Finance
Coldstream Capital Management Inc. Reduces Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Oxford Asset Management LLP Takes $1.25 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc (AMGN) Q1 2025 Earnings: GAAP EPS of $3.20 Beats Estim - GuruFocus
Amgen Swings To Q1 Profit, Beats Street View; Guides FY25 - Nasdaq
Johnson Financial Group Inc. Sells 2,629 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Reports Strong Q1 2025 Financial Results - TipRanks
Amgen Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Spotlight On: Amgen pins hopes on cardiometabolic pipeline - FirstWord Pharma
Amgen Under Pressure, But Seeing Gains Ahead Of Obesity Readouts - insights.citeline.com
Amgen posts profit, says tax policy more effective than tariffs - Reuters
Amgen (AMGN) Reports Strong Q1 2025 Results with Positive Revenue Growth - GuruFocus
Amgen signals strong 2025 outlook with revenue growth and pipeline advancements - MSN
자본화:
|
볼륨(24시간):